New Jersey-based drugmaker Bristol Myers Squibb this month dedicated its first production facility in Indiana, a former north ...

The US Bankruptcy Court for the Southern District of New York recently issued a ruling in In re Giftcraft Ltd., Case No. 25-11030, ...

US President Donald Trump announced on Sunday that the United States was imposing 15-percent tariffs on all European Union ...

This is an audio transcript of the Behind the Money podcast episode: ‘Inside BCG’s Gaza work scandal’ Michela Tindera In the middle of May, the United Nations humanitarian relief chief, Tom Fletcher, ...

For starters, they should use Purdue Pharma’s billions to make Narcan universally accessible.

Purdue Pharma, a Stamford-based drug maker that has faced billions in fines for misleading the public on its addictive opioid OxyContin, has received court approval to pay more than $7.4 […] ...

Oxycontin maker Purdue Pharma received court approval on Friday to begin voting on its $7.4 billion bankruptcy settlement, while deferring questions about how state and local governments should ...

A judge has advanced OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids.

Purdue Pharma’s $7B opioid settlement plan could get votes from victims and cities Members of the Sackler family who own the company would pay up to $7 billion and give up ownership on the company.

About Purdue Pharma L.P. Purdue Pharma and its subsidiaries develop, manufacture and market medications to meet the evolving needs of healthcare professionals, patients, and caregivers.

OxyContin maker Purdue Pharma ‘s $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids will go before a judge Friday, potentially setting up votes on whether to accept it ...

OxyContin maker Purdue Pharma 's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids will be sent to local governments, people who became addicted to the drug and other ...